Navigation Links
PharmaTelevision Turns the Media Spotlight Upon BIO-Europe
Date:10/14/2009

OXFORD, England, October 14 /PRNewswire/ -- PharmaTelevision(R), the authoritative channel for the pharmaceutical, biotechnology and related industries, today announced that it is teaming up with the EBD Group to offer delegates at BIO-Europe a Television Interview and Media Training.

Dr Fintan Walton, CEO of PharmaVentures - the company behind PharmaTelevision - said, "Standing out and attaining share of voice is becoming increasingly difficult in the crowded world of biopharma partnering. Effective communication that makes an impact is critical for attracting partners and winning deals. That is why we have devised this unique package for BIO-Europe delegates."

Dr Walton continues, "By offering media training, we are helping to make our interviewees excellent communicators through the medium of television."

To find out more about BIO-Europe 2009: Television Interview and Media Training Opportunity from PharmaTelevision, please visit:

http://www.pharmatelevision.com/BIOEurope2009.aspx

About PharmaTelevision(R)

PharmaTelevision is the groundbreaking online TV channel for the biopharma industry, offering daily television news, analysis and feature interviews with industry leaders. Since May 2006, it has rapidly grown and the channel now boasts a global audience of 10,000+ viewers including top industry executives.

PharmaTelevision is produced by professional television industry experts using professional studios worldwide as well as its own studios in Oxford, England.

PharmaTelevision produces Open Access Content as well as subscription based Premium Content.

Open Access Content includes the Regional Report - a programme that focuses on the key locations for pharmaceutical and biotech investment, the Financial Report - a programme focused on companies and their performance and the Business Network - a series of interviews and profiles of some of the leading companies in biotech.

Premium Content includes PharmaTelevision News - a daily news and analysis programme, PharmaTelevision News Review - a programme featuring interviews, panel discussions and analysis with leading experts and leaders in our industry and the Business Report - a programme that analyses key business and market trends in our industry.

About PharmaVentures

A leading results driven organisation, PharmaVentures ( http://www.pharmaventures.com) assists pharmaceutical and biotechnology companies across the world in all aspects of deal making and business intelligence. The Company provides tailored corporate advisory services to the Life Science industry, with additional deal making support provided through the PharmaDeals(R) range of intelligence products that include analysis tools and reports. An innovative business, PharmaVentures additionally provides industry insight through the world's first dedicated online pharmaceutical television channel http://www.pharmatelevision.com.

Now in its 17th year, PharmaVentures is based in Oxford, UK, employs over 50 people mostly educated to PhD or above, and has increased its turnover five fold with 80% of revenues from outside the UK. With offices in the USA and Australia, the Company works for a variety of clients from start-ups to global corporate pharmaceutical companies.

PharmaTelevision(R) and PharmaDeals(R) are registered Trade Marks of PharmaVentures Ltd.

SOURCE PharmaTelevision


'/>"/>
SOURCE PharmaTelevision
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PharmaTelevision Launches the First Daily News Show for the Life Sciences Industry
2. Toward worlds smallest radio: nano-sized detector turns radio waves into music
3. One of Nations Oldest Blood Services Providers Turns to Sysmex America
4. Cystic Fibrosis Trial In Children Returns Positive Data
5. Cord Blood America Reports CorCell, Its Major Acquisition in 2006, Turns Profitable
6. Online Career Service Turns Focus to Switching Gears
7. NanoMedicine Summit Returns to Cleveland, September 25-26
8. MEDICA 2008 Returns in November
9. Rexin-G Returns to The Big Apple: Clinical Trials for Pancreatic Cancer and Breast Cancer Open in Manhattan
10. Court of Appeals Overturns 2005 Patent Verdict Against Cordis
11. Marriott Resort Magically Turns Brown Grease "Green" With The Cost-Cutting Hydrologix GRS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... Early-career researchers from Indonesia , ... and Yemen honored ... Indonesia , Nepal , Peru ... are being honored for their accomplishments in nutrition, psychiatry, biotechnology, women,s health, ... scientists who are pursuing careers in agriculture, biology and medicine in their ...
(Date:2/10/2016)... -- NX Prenatal Inc., a US based molecular ... early warning of adverse pregnancy outcomes, announced today ... Dr. Thomas McElrath of Brigham & ... (SMFM) annual meeting held in Atlanta ... presentation reported initial positive top-line results regarding the ...
(Date:2/10/2016)... (PRWEB) , ... February 10, ... ... REGN) today announced that it has joined the Human Vaccines Project, a ... infectious diseases and cancer. , The Human Vaccines Project brings together ...
(Date:2/10/2016)...  Allergan plc (NYSE: AGN ) a leading ... , Allergan,s CEO and President, will be featured as ... the RBC Capital Markets Healthcare Conference on Tuesday, February ... York Palace Hotel in New York, NY ... can be accessed on Allergan,s Investor Relations web site ...
Breaking Biology Technology:
(Date:2/9/2016)... Vigilant Solutions announces today that an agency used its Vigilant ... in a difficult homicide case. The agency then used Vigilant,s ... vehicle. Due to the ongoing investigation, the agency name and ... agency,s request. --> --> ... deceased at an intersection here in the City. He had ...
(Date:2/3/2016)... , February 4, 2016 --> ... to SEK 1,351.5 M (105.0), up 1,187% compared with fourth quarter of ... amounted to SEK 517.6 M (loss: 30.0). Earnings per share ... activities was SEK 537.4 M (neg: 74.7). , ... , Revenues amounted to SEK 2,900.5 M (233.6), up 1,142% compared with ...
(Date:2/2/2016)... Feb. 2, 2016  BioMEMS devices deployed ... focused on medical screening and diagnostic applications, ... Wearable devices that facilitate and assure continuous ... movement are being bolstered through new opportunities ... signal acquisition coupled with wireless connectivity and ...
Breaking Biology News(10 mins):